E. CERESA

Modulation of TAFI function through different pathways – implications for the development of TAFI inhibitors

Ann Gils, E. CERESA, A.M. MACOVEI et al. · Journal of Thrombosis and Haemostasis · 2005 · 47 citations

Molecular Pharmacology, Signal Transduction, Signaling Pathway +10

Development of ELISAs Measuring the Extent of TAFI Activation

E. CERESA, Els Brouwers, Miet Peeters et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2005 · 41 citations · Full text

Generation of a Stable Activated Thrombin Activable Fibrinolysis Inhibitor Variant

E. CERESA, Kirsten Van de Borne, Miet Peeters et al. · Journal of Biological Chemistry · 2006 · 31 citations · Full text

Tafia Half-life, Molecular Biology, Biomedical Engineering +20

Comparative evaluation of stable TAFIa variants: importance of α‐helix 9 and β‐sheet 11 for TAFIa (in)stability

E. CERESA, Marc De Maeyer, Abel Jonckheer et al. · Journal of Thrombosis and Haemostasis · 2007 · 15 citations · Full text

Biochemistry, Natural Sciences, Molecular Biology +3